Cargando…
Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities
Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, r...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802190/ https://www.ncbi.nlm.nih.gov/pubmed/29328413 http://dx.doi.org/10.3892/mmr.2018.8377 |
_version_ | 1783298496567181312 |
---|---|
author | Dehbozorgi, Mahshid Kamalidehghan, Behnam Hosseini, Iman Dehghanfard, Zahra Sangtarash, Mohammad Hossein Firoozi, Maryam Ahmadipour, Fatemeh Meng, Goh Yong Houshmand, Massoud |
author_facet | Dehbozorgi, Mahshid Kamalidehghan, Behnam Hosseini, Iman Dehghanfard, Zahra Sangtarash, Mohammad Hossein Firoozi, Maryam Ahmadipour, Fatemeh Meng, Goh Yong Houshmand, Massoud |
author_sort | Dehbozorgi, Mahshid |
collection | PubMed |
description | Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. In the current study, the frequency of the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles in an Iranian population cohort of different ethnicities were examined and then compared with previously published frequencies within other populations. Allelic and genotypic frequencies of the CYP2C19 alleles (*2, *3 and *17) were detected using polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, PCR-single-strand conformation polymorphism analysis and DNA sequencing from blood samples of 1,229 unrelated healthy individuals from different ethnicities within the Iranian population. The CYP2C19 allele frequencies among the Iranian population were 21.4, 1.7, and 27.1% for the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. The frequency of the homozygous A/A variant of the CYP2C19*2 allele was significantly high and low in the Lur (P<0.001) and Caspian (P<0.001) ethnicities, respectively. However, the frequency of the homozygous A/A variant of the CYP2C19*3 allele was not detected in the Iranian cohort in the current study. The frequency of the heterozygous G/A variant of the CYP2C19*3 allele had the significantly highest and lowest frequency in the Fars (P<0.001) and Lur (P<0.001) groups, respectively. The allele frequency of the homozygous T/T variant of the CYP2C19*17 allele was significantly high in the Caspian (P<0.001) and low in the Kurd (P<0.05) groups. The frequency of the CYP2C19 alleles involved in drug metabolism, may improve the clinical understanding of the ethnic differences in drug responses, resulting in the advancement of the personalized medicine among the different ethnicities within the Iranian population. |
format | Online Article Text |
id | pubmed-5802190 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-58021902018-02-26 Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities Dehbozorgi, Mahshid Kamalidehghan, Behnam Hosseini, Iman Dehghanfard, Zahra Sangtarash, Mohammad Hossein Firoozi, Maryam Ahmadipour, Fatemeh Meng, Goh Yong Houshmand, Massoud Mol Med Rep Articles Polymorphisms in the cytochrome P (CYP) 450 family may cause adverse drug responses in individuals. Cytochrome P450 2C19 (CYP2C19) is a member of the CYP family, where the presence of the 681 G>A, 636 G>A and 806 C>T polymorphisms result in the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. In the current study, the frequency of the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles in an Iranian population cohort of different ethnicities were examined and then compared with previously published frequencies within other populations. Allelic and genotypic frequencies of the CYP2C19 alleles (*2, *3 and *17) were detected using polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, PCR-single-strand conformation polymorphism analysis and DNA sequencing from blood samples of 1,229 unrelated healthy individuals from different ethnicities within the Iranian population. The CYP2C19 allele frequencies among the Iranian population were 21.4, 1.7, and 27.1% for the CYP2C19*2, CYP2C19*3 and CYP2C19*17 alleles, respectively. The frequency of the homozygous A/A variant of the CYP2C19*2 allele was significantly high and low in the Lur (P<0.001) and Caspian (P<0.001) ethnicities, respectively. However, the frequency of the homozygous A/A variant of the CYP2C19*3 allele was not detected in the Iranian cohort in the current study. The frequency of the heterozygous G/A variant of the CYP2C19*3 allele had the significantly highest and lowest frequency in the Fars (P<0.001) and Lur (P<0.001) groups, respectively. The allele frequency of the homozygous T/T variant of the CYP2C19*17 allele was significantly high in the Caspian (P<0.001) and low in the Kurd (P<0.05) groups. The frequency of the CYP2C19 alleles involved in drug metabolism, may improve the clinical understanding of the ethnic differences in drug responses, resulting in the advancement of the personalized medicine among the different ethnicities within the Iranian population. D.A. Spandidos 2018-03 2018-01-05 /pmc/articles/PMC5802190/ /pubmed/29328413 http://dx.doi.org/10.3892/mmr.2018.8377 Text en Copyright: © Dehbozorgi et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Dehbozorgi, Mahshid Kamalidehghan, Behnam Hosseini, Iman Dehghanfard, Zahra Sangtarash, Mohammad Hossein Firoozi, Maryam Ahmadipour, Fatemeh Meng, Goh Yong Houshmand, Massoud Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title | Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title_full | Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title_fullStr | Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title_full_unstemmed | Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title_short | Prevalence of the CYP2C19*2 (681 G>A), *3 (636 G>A) and *17 (−806 C>T) alleles among an Iranian population of different ethnicities |
title_sort | prevalence of the cyp2c19*2 (681 g>a), *3 (636 g>a) and *17 (−806 c>t) alleles among an iranian population of different ethnicities |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802190/ https://www.ncbi.nlm.nih.gov/pubmed/29328413 http://dx.doi.org/10.3892/mmr.2018.8377 |
work_keys_str_mv | AT dehbozorgimahshid prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT kamalidehghanbehnam prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT hosseiniiman prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT dehghanfardzahra prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT sangtarashmohammadhossein prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT firoozimaryam prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT ahmadipourfatemeh prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT menggohyong prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities AT houshmandmassoud prevalenceofthecyp2c192681ga3636gaand17806ctallelesamonganiranianpopulationofdifferentethnicities |